The Prognosis of Advanced Non-Small Cell Lung Cancer Patients with Precision-Targeted Therapy Guided by NGS Testing or Routine Testing

PURPOSE: We aim to observe the potential survival benefits of driver gene-guided targeted therapy in advanced non-small cell lung cancer (NSCLC) patients compared to non-targeted therapy. Additionally, the study aims to assess whether Next-generation sequencing technology (NGS)-guided targeted thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Tingting, Chen, Dandan, Jiang, Houjun, Ma, Jianhua, Wang, Hongwei, Chen, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658950/
https://www.ncbi.nlm.nih.gov/pubmed/38027245
http://dx.doi.org/10.2147/CMAR.S436808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658950/
https://www.ncbi.nlm.nih.gov/pubmed/38027245
http://dx.doi.org/10.2147/CMAR.S436808

Ejemplares similares